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Camera Phone-Based Quantitative Analysis of
C-Reactive Protein ELISA
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Abstract—We demonstrate the use of a camera phone as a low-
cost optical detector for quantitative analysis of a high-sensitivity
C-reactive protein (hs-CRP) enzyme-linked immunosorbent assay
(ELISA). The camera phone was used to acquire images of the
ELISA carried out in a conventional 96 well plate. Colorimetric
analysis of the images was used to determine a standard curve that
exhibited excellent agreement with a fitted 4-parameter logistic
model      . The limit of detection (LOD) for this ap-
proach was determined to be  	   
    
   CRP. Furthermore, these results were found to be
in very close agreement with measurements obtained for the same
assay using a laboratory-based instrument. These findings indicate
the basic technology to enable low-cost quantitative home-based
monitoring of an important clinical biomarker of inflammatory
disease may already be present in the patient’s home.
Index Terms—Camera phone, C-reactive protein, en-
zyme-linked immunosorbent assay (ELISA), inflammatory
disease, quantitative biomarker detection.
I. INTRODUCTION
T HERE is growing recognition among healthcare stake-holders that patient-centric models of healthcare delivery
are both highly cost-effective and beneficial to the patient.
In particular, home-based self-monitoring is now a tangible
reality for individuals with adequately controlled or stable
chronic disease. In such applications, clinical management
requires quantitative biomarker information in order to accu-
rately monitor and assess treatment progress. Currently, most
testing for biomarkers is carried out in centralised laboratories
or at the point-of-care (e.g., doctor’s clinic) using specialised
techniques and measurement equipment. One such technique
is the enzyme-linked immunosorbent assay (ELISA). Typi-
cally, ELISAs are carried out in well plates that are analyzed
optically using expensive plate reader instruments that em-
ploy spectrophotometric techniques to determine biomarker
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concentration. However, to fully realize the potential benefits
of home-based self-monitoring of disease it will be necessary
to develop alternative low-cost technologies that enable the
detection and quantification of biomarkers in non-traditional
settings such as the home. In this context, the ability to develop
low-cost ELISA-based diagnostic tests has significant poten-
tial and a number of parallel approaches have been reported
that address the development of alternative low-cost optical
detection strategies [1]–[3] and assay platforms [4]–[8] for this
purpose. However, the ability to leverage the ubiquitous nature
of camera phone technology as an optical detection platform
for analytical applications in healthcare has transformative
potential.
Camera phones have been used in a number of analytical
applications to acquire images that can be analyzed, either
in-situ (i.e., by the phone) or remotely, in order to determine
quantitative information. For example, camera phones have
been demonstrated to enable: in-situ quantitative assessment
of UV exposure in solar disinfection of water [9], real-time
detection of trace gases and contaminants [10], [11], detection
of biomarkers using lateral flow strips [12] and other novel
diagnostic tests [13].
With 50–80% of global health spending related to chronic dis-
ease [14], there is clear impetus for the development of more ef-
ficient and cost-effective methods of disease management. The
use of camera phones as a low-cost health-enabling technology
to support self-monitoring of chronic disease may be one such
approach. However, adaptation will depend on their ability to
detect biomarkers relevant to the management of chronic dis-
ease.
Inflammation is the underlying basis of a number of impor-
tant chronic diseases including cardiovascular disease (CVD),
rheumatoid arthritis (RA) and inflammatory bowel disease
(IBD). C-reactive protein (CRP) is one of the most widely used
biomarkers of inflammation. CRP is an acute phase reactant
that is released from the liver during an inflammatory response
to tissue injury, infection, malignancy and autoimmunity. The
blood concentration of CRP is routinely used to indicate the
degree of inflammation in chronic inflammatory diseases such
as CVD [15], RA [16], Crohn’s disease [17] and psoriasis [18].
More recently, the utility of high-sensitivity CRP (hs-CRP)
assays, which are capable of detecting very low concentrations,
has been highlighted both in rheumatology as a means of
assessing clinical remission [16] and in the as-
sessment of CVD risk ( —low, 1–3 —average,
—high) [15]. In this work, we demonstrate the use
of camera phone imaging in the quantitative analysis of a
hs-CRP ELISA. This work may have significant implications
for the development of low-cost measurement technologies that
1932-4545/$31.00 © 2013 IEEE
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enable home-based self-monitoring of a number of significant
chronic inflammatory diseases.
II. EXPERIMENTAL
A. High-Sensitivity C-Reactive Protein ELISA
The hs-CRP ELISA was carried out in a standard 96 well
plate using three assay replicates of 7 known concentrations
(including blank) and one unknown sample for testing. These
known concentrations are used to determine a standard (i.e., cal-
ibration) curve. The assay was performed by first adding 100
of 5 rabbit anti-human CRP capture antibody to each
well and incubating for 1 hr at 37 . The plate was blotted to
remove unbound antibody and blocked with 200 of 5% BSA
in PBS (pH 7.4) for 1 hr at 37 (Sigma, Ireland). The plate
was then washed 3 times with PBS. CRP antigen (Hytest, Fin-
land) concentrations were prepared in PBS (0–5 ) and
incubated on the plate for 1 hr at 37 . The plate was washed
5 times with PBST (0.05% Tween) and PBS before the addition
of 100 per well of 10 detection antibody C5 (Hytest,
Finland) for one hour at 37 . The plate was washed a fur-
ther five times with PBST and PBS. 100 of 1:1000 conjugate
anti-mIgG-HRP (Sigma, Ireland) was added to each well and
incubated for 1 hour at 37 . The wells were washed 5 more
times with PBST and PBS before the addition of 50 TMB en-
zyme substrate (Sigma, Ireland). The plate was left to develop
for 10 minutes and images of the plate were obtained with the
camera phone.
B. Camera Phone Image Acquisition and Analysis
The camera phone used in this work was a Nokia N96 smart-
phone which employs an 8-bit 2592 1944 pixel RGB image
sensor. To provide a uniform background for the images, a sheet
of plain white paper was placed beneath the well plate. The
phone was positioned directly above the well plate at a distance
of approx. 12 cm. The large number of pixels available in this
image sensor provides high spatial sampling of the image which
is advantageous for this type of application where the smart-
phone is placed at a distance from the object of interest (i.e.,
well plate). To reduce shadowing caused by the phone and over-
head lighting, a standard desk lamp (40 W bulb) was located
above the well plate and inclined at an angle of 50 degrees to
the surface of the bench top. A total of five images were ac-
quired using the phone’s camera and stored in memory. The
camera’s flash was disabled during image acquisition. To as-
sess the camera phone-based method, we compared its perfor-
mance to that of a standard analysis of the well plate carried
out using a laboratory plate reader. For this standard analysis,
the reaction was stopped immediately after acquisition of the
camera phone images by adding 50 of 0.1 M hydrochloric
acid (HCl) to each well. The plate was then placed in the plate
reader (TECAN Infinite M200, TECAN, Switzerland) and the
sample absorbance at 450 nm measured. The absorbance values
obtained for a given concentration were then averaged and the
standard deviation determined. The addition of HCl results in
each of the samples turning yellow. However, the camera phone
Fig. 1. Representative image of standard 96 well plate acquired by mo-
bile phone (cropped for display purposes). (a) Assay region of well plate.
(b)  -channel image of assay region.
images were acquired prior to the addition of HCl hence the so-
lutions remains blue. Fig. 1(a) shows a representative image of
the well plate obtained using the camera. Each assay replicate
occupies a separate row of the plate with sample concentration
decreasing from left-to-right. The second last well in each row
contains the blank while the last contains the unknown sample.
The images were then transferred from the camera phone to a
personal computer and analysed using custom-software devel-
oped in the MATLAB (MathWorks Inc.) environment. The im-
ages were then transformed from the native camera RGB color
space to the normalised RGB color space to reduce the ef-
fect of variations in illumination intensity [19]. The normalised
blue channel ( -channel) was selected for all subsequent image
analysis. The decision was based on the analysis detailed in Sec-
tion II-C. Fig. 1(b) shows the assay region of the corresponding
-channel image shown in Fig. 1(a). Following transformation,
the average of a sample of (11 11 pixel re-
gion) from each well was calculated. Since the sample volume
in each well was constant, this average response was used as a
measure of analyte concentration. This procedure was repeated
for each well in all images. The responses for corresponding
concentrations within each image for each replicate were then
averaged to produce a 3 8 (replicate sample) matrix. The
calibration data were determined by averaging the columns of
this matrix. The standard deviation of these values was used as
a measure of inter-replicate variability.
C. Color Channel Selection
Our motivation for acquiring images prior to the addition of
HCl was based on an analysis of the camera’s color detection
performance. A challenge associated with the use of imaging
devices that implement the RGB color model is that this color
model is device dependent [20]. Consequently, it is necessary
to evaluate which of the three color channels provides the best
detection performance for a particular measurement application
since the manner in which color is detected can change from one
device to another.
To do this, we performed a number of experiments in which
images of the assay were acquired before and after the addi-
tion of HCl. Each of the normalised color channels (i.e., ,
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TABLE I
COLOR CHANNEL ANALYSIS
and ) were analysed in the manner described previously. Based
on these response data, the range (i.e., difference between max-
imum and minimum response) and maximum uncertainty (es-
timated as the standard deviation) for each channel was deter-
mined. The ratio of the range and the uncertainty was calculated
and used as an estimate of the each channel’s signal-to-noise
ratio (SNR). Table I shows representative results of this anal-
ysis which indicates that the -channel, when used in conjunc-
tion with an assay that is not stopped, is optimal in terms of SNR
(18.691).
In addition to this measure, it is also important to consider the
nature of the channel response to changes in analyte concentra-
tion. As stated previously, the image sensor used in the camera
phone is an RGB sensor. The RGB color model is an additive
color model that represents/detects color as a summation of the
three primary color components. This model is device depen-
dent which means that different devices will represent the same
color differently. For this application, the manner in which color
is detected can have significant implications for an assessment
of assay performance.
For a ligand-binding assay, the measured response is ex-
pected to follow a curve that is sigmoidal in shape with a lower
boundary (asymptote) near the minimum response and an upper
asymptote near the maximum response. For data of this shape,
the 4-parameter logistic model is generally acknowledged to
be the reference model of choice for fitting [21]. In turn, this
model forms the basis for the determination of a number of
performance characteristics such as limit of detection (LOD),
linear range and relative error (RE). Consequently, it is im-
portant to verify that the channel selected for analysis exhibits
this expected response in order to validate the performance of
the camera phone-based technique with that of the standard
laboratory approach.
Fig. 2 shows response data for each color channel of the
image sensor. It is clear that the -channel provides the expected
sigmoidal response and exhibits a sufficiently wide range of re-
sponse (0.273) with low noise (0.015) for measurement (as in-
dicated by the previously described SNR measure). In the case
of the -channel, the response is also sigmoidal in shape but
does not exhibit a sufficiently large range (0.065). In fact, the
-channel is observed to be relatively insensitive to changes in
sample concentration. Finally, the -channel response data do
not have the expected shape since a measurable response cannot
be obtained at higher concentrations (i.e., 5.0 and 1.0 ).
Fig. 2. Normalised color channel response as a function of CRP concentration
(error bars    ). (Blanks not shown).
This means that it may not be possible to reliably fit the data in
this channel to a 4-parameter logistic model since this portion
of the fitted model will be unbound.
III. RESULTS & CONCLUSION
Following from the analysis of color channel performance,
the response data of the -channel was fitted to a 4-parameter
logistic model (1) in order to assess system performance.
(1)
In this model, is the response (e.g., camera phone color
channel value or laboratory instrument absorbance value),
is the concentration, is the upper asymptote, is the
lower asymptote, is the model EC50 (the concentration
corresponding to midway between the modeled estimates of
minimum and maximum response) and is the so-called
slope factor.
Table II shows the response data obtained from the analysis
of the 96 well plate using the standard laboratory instrument
along with the -channel response of the camera phone. Table III
shows the fitted logistic model parameter values and the good-
ness of fit measures determined in each case. The camera phone
data were found to exhibit excellent agreement
when fitted with the logistic model and closely agreed with the
standard curve obtained using the laboratory instrument. Fig. 3
shows the standard curves obtained using the laboratory instru-
ment and the -channel of the camera phone along with the fitted
4-parameter logistic models.
The fitted 4-parameter logistic models were then used to es-
timate the limit of detection (LOD) for each method by deter-
mining the concentration at which the response is equal
to
(2)
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TABLE II
ELISA ANALYSIS RESULTS
TABLE III
LOGISTIC MODEL PARAMETERS
Fig. 3. hs-CRP ELISA standard curves obtained using camera phone and lab-
oratory instrument (error bars    ). (Blanks not shown.)
where is the average blank response and is the
blank response standard deviation. Using this approach, (2) is
substituted for in (1) which is then rearranged for which
becomes the LOD to give
(3)
The LOD for the camera phone-based method and labora-
tory instrument were determined to be
and
CRP respectively. Using the method described
in [22], the linear regions of the standard curves for the
camera phone and laboratory instrument were found to be
0.035–0.182 (1.394–7.249 ) and 0.043–0.302
(1.712–12.03 ) CRP respectively. In both cases, the relative
error (RE) in the linear regions was determined to be 10%.
The unknown CRP concentration range was determined to be
0.040–0.055 (1.593–2.191 ) using the camera phone
and 0.044–0.056 (1.752–2.230 ) using the laboratory
instrument. These ranges compare favorably with the nominal
unknown concentration of 0.055 (2.191 ).
These results clearly demonstrate that it is possible to per-
form quantitative analysis of a hs-CRP ELISA using a camera
phone as an alternative low-cost optical detector. Moreover,
this work shows that the basic imaging performance of a
commercial camera phone can be used in conjunction with
a suitably developed assay to enable quantitative measure-
ment of CRP concentrations at clinically relevant levels with
performance comparable to a standard laboratory technique.
Clearly, this result has broad ramifications for the development
of low-cost point-of-care (POC) technologies in general, how-
ever, specifically, it indicates a basic technology (i.e., optical
detection platform) to enable remote quantitative monitoring of
an important inflammatory biomarker used in the management
of a number of chronic diseases (e.g., CVD, RA and IBD) may
already be present in the patient’s home.
As the global socio-economic burden of disease becomes
more apparent, there is now growing interest in the develop-
ment of connected- and mobile-health (mHealth) technologies
to reduce this burden and enhance patient quality of life.
In this regard, the innovative integration of technologies for
the diagnosis and management of disease will play a crucial
role. For example, the use of camera phones and microfluidic
biochips has been demonstrated in the detection of cancer
cells [23]. While this work represents an excellent technology
demonstrator, the use of mobile phone-based technologies is
more likely to find greater application in the monitoring of
disease rather than in its diagnosis.
In future work, we will further develop and optimize the ap-
proach described here and investigate the use of microfluidic
biochips and on-phone image analysis to provide a convenient,
sample-to-result testing system for home-based monitoring of
CRP. In this context, we have demonstrated that this is feasible
given that the assay we describe has a relatively short incubation
time and can be analysed in-situ using a camera phone. Further-
more, the elimination of the reaction stopping step reduces the
number of reagents that must be stored on such a microfluidic
chip and can reduce the complexity of the microfluidic architec-
ture used. It is anticipated that the development of such a system
could have a significant impact on the management of chronic
inflammatory disease but also have broader application in other
areas such as in the treatment of sepsis [24], prediction of heart
disease and stroke [25], monitoring immune system response in
cancer patients [26] as well as providing a means of monitoring
wellness [27].
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